bioRxiv Science⌕ Search

bioRxiv · 10.1101/628339

K. pneumoniae ST258 genomic variability and bacteriophage susceptibility

Abstract

Multidrug resistant carbapenemase-producing Klebsiella pneumoniae capable of causing severe disease in humans is classified as an urgent threat by health agencies worldwide. Bacteriophages are being actively explored as potential therapeutics against these multidrug resistant pathogens. We are currently developing bacteriophage therapy against carbepenem-resistant K. pneumoniae belonging to the genetically diverse, globally disseminated clonal group CG258. In an effort to define a robust experimental approach for effective selection of lytic viruses for therapy, we have fully characterized the bacterial genomes of 18 target strains, tested them against novel lytic bacteriophages, and generated phage-susceptibility profiles. The genomes of K. pneumoniae isolates carrying blaNDM and blaKPC were sequenced and isolates belonging to CG258 were selected for susceptibility testing using a panel of lytic bacteriophages (n=65). The local K. pneumoniae CG258 population was dominated by isolates belonging to sequence type ST258 clade 1 (86%). The primary differences between ST258 genomes were variations in the capsular locus (cps) and in prophage content. We showed that CG258-specific lytic phages primarily target the capsule, and that successful infection is blocked in many, post-adsorption, by immunity conferred by existing prophages. Five bacteriophages specifically active against K. pneumoniae ST258 clade 1 (n=5) belonging to the Caudovirales order were selected for further characterization. Our findings show that effective control of K. pneumoniae CG258 with phage will require mixes of diverse lytic viruses targeting all relevant cps variants and allowing for variable prophage content. These insights will facilitate identification and selection of therapeutic phage candidates against this serious pathogen.\n\nImportanceBacteriophages are natural agents that exclusively and selectively kill bacteria and have the potential to be useful in the treatment of multidrug resistant infections. K. pneumoniae CG258 is a main agent of life-threatening sepsis that is often resistant to last-line antibiotics. Our work highlights some key requirements for developing bacteriophage preparations targeting this pathogen. By defining the genomic profile of our clinical K. pneumoniae CG258 population and matching it with bacteriophage susceptibility patterns, we found that bacteriophage ability to lyse each strain correlates well with K. pneumoniae CG258 structural subtypes (capsule variants). This indicates that preparation of bacteriophage therapeutics targeting this pathogen should aim at including phages against each bacterial capsular subtype. This necessitates a detailed understanding of the diversity of circulating isolates in different geographical areas in order to make rational therapeutic choices.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Venturini, C., Ben Zakour, N., Bowring, B., Morales, S., Cole, R., Kovach, Z., Branston, S., Kettle, E., Thomson, N., Iredell, J.. 2019-05-05. K. pneumoniae ST258 genomic variability and bacteriophage susceptibility. https://doi.org/10.1101/628339

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Genomic analysis of the Streptococcus anginosus group; taxonomic implications, evolutionary insights and clinical considerations

Background: The Streptococcus anginosus group (SAG) (S. anginosus, S. intermedius, and S. constellatus) causes serious, potentially life-threatening, invasive infections, often in otherwise healthy individuals. However, the group's diversity is still poorly understood, and with it, the ability to identify prognostic markers of severe disease. Methods: Long-read sequencing produced closed genomes for 29 isolates from 25 patients hospitalised primarily for invasive SAG infections, and 21 isolates from 20 non-hospitalised controls. Genomes were classified with GTDB-Tk and combined with 211 reference genomes. After dereplication, 207 SAG genomes (38 isolate, 169 reference) representing 206 strains were analysed using: GTDB classification, average nucleotide identity, multi-marker and core-genome SNP phylogenies, recombination-aware analyses, mobilome, CAZyme and gapseq metabolic profiling, and lineage-aware genome-wide association testing for invasive phenotype. Results: Agreement between GTDB-Tk and MALDI-TOF taxonomic classifications was low (42.8%), including two S. massiliensis cases mis-identified by MALDI-TOF as SAG. S. anginosus resolved into four taxa (S. anginosus, S. hominis, S. whileyi and S. vaginalis). Phylogenies based on core genome single-nucleotide polymorphisms resolved these species into distinct clades, whereas 16S rRNA gene and multilocus sequence analysis phylogenies did not. The four ex-S. anginosus taxa showed a gradient of genomic cohesion, with S. vaginalis being near-clonal, in contrast to S. anginosus, which shared high levels of sequence ancestry with other neighbouring taxa. Carbohydrate utilisation was strongly lineage-associated, as was propensity for invasive disease. A ~15Kbp glycosaminoglycan utilisation locus was found in the three taxa of highest disease severity propensity (S. intermedius, S. constellatus, S. whileyi) which predicts a direct host glycosaminoglycan feeding mechanism that may contribute to invasive disease. No single functional feature, gene or core-genome SNP was associated with invasiveness however after lineage-adjustment. Combined feature analysis suggests S. vaginalis has undergone a niche restriction and has evolved for a primary existence in the female urogenital tract. Conclusions: Under-reported species may be mis-diagnosed as SAG invasive infections. SAG is more diverse than its current three-species definition, with the conventional S. anginosus species proposed to be classed into a complex of four distinct taxa. Invasive capacity appears to be an emergent system-level property rather than from individual features.

microbiology↗

Cell-scale confinement reorders bacterial speed rankings

Which bacterium swims fastest depends on where the race is run. Speeds are usually measured in open liquid, yet many bacteria live in pores, mucus and host passages no wider than a cell. Using a microfluidic device with eight channel widths (0.80-3.00 m) in one field of view, we tracked unlabeled cells of eight species spanning five motility systems. Chamber height, a polymer additive and channel width each reordered the ranking. Vibrio alginolyticus, the fastest in open liquid, slowed to ~4 m/s in 1.25-m channels, whereas Campylobacter jejuni and Bacillus subtilis kept 33-46 m/s. Open liquid speed did not predict robustness to confinement. In two unrelated lineages, host symbionts that pass through narrow passages during colonization, Caballeronia insecticola and Vibrio fischeri, outran their non-symbiotic relatives in the channels, and crossed them with flagella wrapped around the cell body at nearly the speed of unwrapped cells. Where space is tight, the ability to keep moving, not top speed, sets the ranking.

microbiology↗

The biochemical composition of coronavirus Nucleocapsid proteins drives the bicistronic properties of their sub-genomic mRNAs

The nucleocapsid (N) gene of coronaviruses (CoVs) encodes a structural RNA-binding protein required for viral assembly. In SARS- and MERS-CoV viruses, reading frame 2 of N contains an overlapping open reading frame (ORF) encoding an innate immune antagonist accessory protein. However, the extent of this dual coding capacity across the CoV family, and the genetic features driving overlapping ORF formation, remain unexamined. Here, we developed an in-silico tool (ORFan) to screen structural gene sub-genomic mRNA sequences from 152 species of coronavirus for the presence of overlapping accessory gene candidates. We found that frame 2 of the N gene in Alpha-, Beta- and Delta-CoVs frequently contains a potential accessory ORF (AcORF), conserved at the subgenus level, unlike the spike, envelope and membrane genes. We also show that CoV nucleotide biases in conjunction with codon biases integral to N protein function drive the relatively high abundances of start codons in frame two and stop codons in frame three, explaining the tendency towards frame 2 AcORFs. We further suggest that viral nucleotide biases and the codon composition required for RNA-binding function facilitate overlapping ORF formation in other virus families

microbiology↗